Basic Information
Basic information for C5orf64-214-41aa
Peptide Name C5orf64-214-41aa
Genome Position chr5:61759993-61760115[+]
Species Human
Peptide Sequence MLLVRCLRILCLTTVRNTEKFVIWENTGCFLLHLLLTFVFF
Peptide Length 41
Unique No (C5orf64-216-41aa-2,C5orf64-220-41aa)
Grand Average of Hydropathicity 1.1659
Relative Molecular Mass 5638.82
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000659478;C5orf64-214
Transcript Length 5535
Coding Ability 0.4506
DNA Sequence Corresponding to Peptide ATGCTTTTGGTAAGATGTCTAAGAATTCTTTGCCTAACCACAGTTCGTAATACAGAAAAGTTTGTAATATGGGAAAATACAGGCTGCTTTCTCCTACATTTACTTTTAACATTTGTATTTTTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :